 |
|
Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis
Nagesh Kamat, Sudheer K Vuyyuru, Saurabh Kedia, Pabitra Sahu, Bhaskar Kante, Peeyush Kumar, Mukesh Kumar Ranjan, Mukesh Kumar Singh, Sambuddha Kumar, Vikas Sachdev, Govind Makharia, Vineet Ahuja
Intest Res. 2022;20(2):269-273. Published online 2022 Feb 8 DOI: https://doi.org/10.5217/ir.2021.00064
|
|
Citations to this article as recorded by
 Depression and active disease are the major risk factors for fatigue and sleep disturbance in inflammatory bowel disease with consequent poor quality of life: Analysis of the interplay between psychosocial factors from the developing world
Partha Pal, Rupa Banerjee, Polina Vijayalaxmi, D. Nageshwar Reddy, Manu Tandan
Indian Journal of Gastroenterology.2024; 43(1): 226. CrossRef Research Progress in the Study of Biomarkers for Diagnosing Ulcerative Colitis or Assessing Its Activity
琳 杨
Advances in Clinical Medicine.2024; 14(01): 1167. CrossRef A novel serum biomarker of endoscopic mucosal healing in inflammatory bowel disease
Hyoun Woo Kang
Intestinal Research.2024; 22(1): 3. CrossRef The prevalence and burden of Rome IV faecal incontinence in ulcerative colitis: A cross‐sectional study
Dipesh H. Vasant, Gaurav B. Nigam, Sebastian Bate, Shaheen Hamdy, Jimmy K. Limdi
Alimentary Pharmacology & Therapeutics.2023; 58(1): 26. CrossRef Current and emerging biomarkers for ulcerative colitis
Jan K. Nowak, Rahul Kalla, Jack Satsangi
Expert Review of Molecular Diagnostics.2023; 23(12): 1107. CrossRef
|